BIOMAT Database Logo BIOMAT Database Logo

High frequency expressions of CD44 standard and variant forms in non-small cell lung cancers, but not in small cell lung cancers. 1998

K Kondo, and T Miyoshi, and N Hino, and E Shimizu, and N Masuda, and M Takada, and T Uyama, and Y Monden
Second Department of Surgery, School of Medicine, University of Tokushima, Tokushima City, Japan. kondo@clin.med.tokushima-u.ac.jp

OBJECTIVE Organ specificity has been demonstrated in the mode of CD44 expression among several cancers. METHODS We examined the expressions of CD44 standard (CD44s) and CD44 variants (CD44v) in 14 cell lines (small cell lung cancer (SCLC): 5, non-small cell lung cancer (NSCLC): 9 and 20 surgically resected samples (SCLC: 7, NSCLC: 13) of lung cancer using reverse transcription polymerase chain reaction and immunohistochemistry. RESULTS Although both NSCLC and SCLC expressed CD44s, the frequency and intensity of CD44s expression in NSCLC were different from those in SCLC: cell lines, 89% vs. 40%; tumor samples, 100% (diffusely stained) vs. 57% (focally stained). CD44s expression was partially or completely repressed in SCLC. However, NSCLC frequently expressed CD44v, but SCLC expressed infrequently: cell lines, 67% vs. 20%; tumor samples, 69% vs. 0%. The N-417 line, which only expressed some CD44v in SCLC, falls SCLC and NSCLC both in biomarkers and in growth patterns. CONCLUSIONS CD44 expression was repressed in SCLC but was enhanced in NSCLC.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014644 Genetic Variation Genotypic differences observed among individuals in a population. Genetic Diversity,Variation, Genetic,Diversity, Genetic,Diversities, Genetic,Genetic Diversities,Genetic Variations,Variations, Genetic
D018287 Carcinoma, Large Cell A tumor of undifferentiated (anaplastic) cells of large size. It is usually bronchogenic. (From Dorland, 27th ed) Carcinomas, Large Cell,Cell Carcinoma, Large,Cell Carcinomas, Large,Large Cell Carcinoma,Large Cell Carcinomas

Related Publications

K Kondo, and T Miyoshi, and N Hino, and E Shimizu, and N Masuda, and M Takada, and T Uyama, and Y Monden
Standard and variant CD44 isoforms are commonly expressed in lung cancer of the non-small cell type but not of the small cell type.
December 1995, The Journal of pathology,
K Kondo, and T Miyoshi, and N Hino, and E Shimizu, and N Masuda, and M Takada, and T Uyama, and Y Monden
Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
July 1997, Human pathology,
K Kondo, and T Miyoshi, and N Hino, and E Shimizu, and N Masuda, and M Takada, and T Uyama, and Y Monden
CD44 expression in metastatic and non-metastatic non-small cell lung cancers.
October 1997, Cancer letters,
K Kondo, and T Miyoshi, and N Hino, and E Shimizu, and N Masuda, and M Takada, and T Uyama, and Y Monden
PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers.
July 1998, Oncogene,
K Kondo, and T Miyoshi, and N Hino, and E Shimizu, and N Masuda, and M Takada, and T Uyama, and Y Monden
Standard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancer.
January 2016, Oncoimmunology,
K Kondo, and T Miyoshi, and N Hino, and E Shimizu, and N Masuda, and M Takada, and T Uyama, and Y Monden
An integrated analysis of miRNA and mRNA expressions in non-small cell lung cancers.
January 2011, PloS one,
K Kondo, and T Miyoshi, and N Hino, and E Shimizu, and N Masuda, and M Takada, and T Uyama, and Y Monden
[Expression of CD44 standard and CD44 variant 6 in human lung cancer].
November 1997, Nihon Kyobu Shikkan Gakkai zasshi,
K Kondo, and T Miyoshi, and N Hino, and E Shimizu, and N Masuda, and M Takada, and T Uyama, and Y Monden
[Co-expression and prognostic significance of hnRNP B1 and CD44 in non-small cell lung cancers].
September 2008, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition,
K Kondo, and T Miyoshi, and N Hino, and E Shimizu, and N Masuda, and M Takada, and T Uyama, and Y Monden
[Expression of CD44 variant exon 6 in lung cancers].
August 2001, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
K Kondo, and T Miyoshi, and N Hino, and E Shimizu, and N Masuda, and M Takada, and T Uyama, and Y Monden
[Expression of standard and variant CD44 in human lung cancer].
September 1998, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
Copied contents to your clipboard!